bromouracil has been researched along with Acute Promyelocytic Leukemia in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, PO | 1 |
| Larsen, J | 1 |
| Christiansen, J | 1 |
| Larsen, JK | 1 |
1 other study available for bromouracil and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Flow cytometric measurement of RNA synthesis using bromouridine labelling and bromodeoxyuridine antibodies.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Bromouracil; Flow Cytometry; Fluorescein-5-isothiocyanate | 1993 |